GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

But if a drug can be taken with or without food—such as paracetamol—and you want it to work faster, take it on an empty ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Looming threats to pharmaceuticals and the drug supply chain have brought fresh attention to onshoring. Experts say ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

The US Food and Drug Administration (FDA) has issued an urgent warning about tianeptine – a substance marketed as a dietary ...

In the final days of this year’s legislative session, Idaho lawmakers passed a bill to allow pharmacies to sell ivermectin ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...